title: [Clinical practice of dual antiplatelet therapy after percutaneous peripheral arterial interventions in Germany].
abstract: OBJECTIVE
  Guideline recommendations regarding antithrombotic treatment with two antiplatelet agents (dual antiplatelet treatment) after peripheral interventional procedures are vague due to missing data from clinical trials.
  
  
  METHODS
  212 vascular centres in germany were evaluated regarding dual antiplatelet treatment using a standardized questionnaire with differentiation of localisation of the treated artery and interventional methods being used.
  
  
  RESULTS
  89 (42%) questionnaires returned completed. Application and duration of dual antiplatelet treatment after peripheral interventional procedures were quite different regarding interventional methods used (PTA: percutaneous transluminal angioplasty, DCB-PTA: drug coated ballon, Stenting, DES: drug eluting stent, Atherectomy). Mean duration of dual antiplatelet treatment were: PTA iliacal/femoro-popliteal 0 month, crural 1 month; DCB-Intervention and stenting: iliacal 1 month, femoro-popliteal 1,5 months, crural 2 months; DE-stenting iliacal 1,5 months, femoro-popliteal/crural 3 months and after femoro-popliteal / crural atherectomy 1 month.
  
  
  CONCLUSIONS
  Data about dual antiplatelet treatment after peripheral interventional procedures are sparse.
authors.forename: M
authors.initials: M
authors.lastname: Baumhäkel
authors.forename: M
authors.initials: M
authors.lastname: Kindermann
mesh_terms: D017130:Angioplasty / Q000706:statistics & numerical data*; D004359:Drug Therapy, Combination / Q000706:statistics & numerical data*; D005858:Germany; D006782:Hospitals, Special; D006801:Humans; D058729:Peripheral Arterial Disease / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use*; D011795:Surveys and Questionnaires
chemical_list: D010975:Platelet Aggregation Inhibitors